Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Until this week, everything was going marvellously. My size 12 jeans were gaping at the waistline, and I could slip into a ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Plastic surgeons are seeing more patients opting for breast reductions and dissolving facial fillers. They reveal that ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...

Surgical tweaks for “Ozempic face” are on the rise. The latest report from AAFPRS reveals a 50% increase in facial fat ...

If you're looking for cheap growth stocks to buy, three you'll want to consider today are Novo Nordisk (NYSE: NVO), Carnival (NYSE: CCL), and Zoom Communications (NASDAQ: ZM). Here's why these stocks ...

Ram Kapoor left everyone surprised with his drastic physical transformation. The actor, best known for Bade Achhe Lagte Hain, ...

Sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth quarter of last year.